The 29 references in paper M. Khrabrova ., V. Dobronravov A., A. Nabokow ., H. Gröne -J., M. Hallensleben ., A. Smirnov V., V. Kliem ., М. Храброва С., В. Добронравов А., А. Набоков В., Х. Грене -Й., М. Халленслебен ., А. Смирнов В., Ф. Клим . (2015) “Микроваскулярное воспаление как прогностический фактор при трансплантации почки // Microvascular inflammation as a prognostic factor in kidney transplantation” / spz:neicon:nefr:y:2015:i:5:p:34-41

1
Haas M, Sis B, Racusen LC, et al. Banff 2013 Meeting Report: Inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial Lesions. Am J Transplant 2014; 14: 272–283
(check this in PDF content)
2
Solez K, Colvin RB, Racusen LC, et al. Banff ‘05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (‘CAN’). Am J Transplant 2007; 7(3): 518-526
(check this in PDF content)
3
Racusen LC, Colvin RB, Solez K, et al. Antibody-mediated rejection criteria – an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003; 3(6): 708-714.
(check this in PDF content)
4
Papadimitriou JC, Drachenberg CB, Munivenkatappa R, et al. Glomerular inflammation in renal allografts biopsies after the first year: cell types and relationship with antibody-mediated rejection and graft outcome. Transplantation 2010; 90 (12): 1478-1485
(check this in PDF content)
5
Gibson IW, Gwinner W, Bröcker V, et al. Peritubular capillaritis in renal allografts: prevalence, scoring system, reproducibility and clinicopathological correlates. Am J Transplant 2008; 8 (4): 819-825
(check this in PDF content)
6
Cosio FG, Lager DJ, Lorenz EC, et al. Significance and implications of capillaritis during acute rejection of kidney allografts. Transplantation 2010; 89(9): 1088-1094
(check this in PDF content)
7
Loupy A, Hill GS, Suberbielle C, et al. Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA). Am J Transplant 2011; 11(1): 56-65
(check this in PDF content)
8
Hidalgo LG, Campbell PM, Sis B, et al. De novo donorspecific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am J Transplant 2009; 9(11): 2532-2541
(check this in PDF content)
9
Kozakowski N, Herkner H, Böhmig GA, et al. The diffuse extent of peritubular capillaritis in renal allograft rejection is an independent risk factor for graft loss. Kidney Int 2015; Mar 4 [Epub ahead of print]
(check this in PDF content)
10
Verghese P, Dunn T, Najafian B, et al. The impact of C4d and microvascular inflammation before we knew them. Clin Transplant 2013; 27(3): 388-396
(check this in PDF content)
11
Buob D, Grimbert P, Glowacki F, et al. Three-year outcome of isolated glomerulitis on 3-month protocol biopsies of donor HLA antibody negative patients. Transpl Int 2012; 25(6): 663-670
(check this in PDF content)
12
Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44(2): 411-422
(check this in PDF content)
13
Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008; (4): 753-760
(check this in PDF content)
14
Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55 (2): 713-723
(check this in PDF content)
15
Храброва МС, Добронравов ВА, Набоков АВ и др. Прогноз выживаемости почечного трансплантата: иммунологические риски и тип отторжения. Нефрология 2015; [Khrabrova MS, Dobronravov VA, Nabokov AV i dr. Prognoz vyzhivaemosti pochechnogo transplantata: immunologicheskie riski i tip ottorzheniya. Nefrologiya 2015;]
(check this in PDF content)
16
Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130(6): 461-470
(check this in PDF content)
17
Kort H, Willicombe M, Brookes P, et al. Microcirculation inflammation associates with outcome in renal transplant patients with de novo donor-specific antibodies. Am J Transplant 2013;13(2): 485-492
(check this in PDF content)
18
Sis B, Jhangri GS, Riopel J, et al. A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants. Am J Transplant 2012; 12 (5): 1168–1179
(check this in PDF content)
19
Einecke G, Sis B, Reeve J, et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009; 9(11): 2520-2531
(check this in PDF content)
20
Hara S, Matsushita H, Yamaguchi Y, et al. Allograft glomerulitis: histologic characteristics to detect chronic humoral rejection. Transplant Proc 2005; 37(2): 714-716
(check this in PDF content)
21
Tinckam KJ, Djurdjev O, Magil AB. Glomerular monocytes predict worse outcomes after acute renal allograft rejection independent of C4d status. Kidney Int 2005; 68(4): 1866-1874
(check this in PDF content)
22
Batal I, Lunz JG III, Aggarwal N, et al. A critical appraisal of methods to grade transplant glomerulitis in renal allograft biopsies. Am J Transplant 2010; 10 (11): 2442-2452
(check this in PDF content)
23
Loupy A, Suberbielle-Boissel C, Hill GS, et al. Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Am J Transplant 2009; 9(11): 2561-2570
(check this in PDF content)
24
Orandi BJ, Chow EH, Hsu A, et al. Quantifying renal allograft loss following early antibody-mediated rejection. Am J Transplant 2015;15 (2): 489-498
(check this in PDF content)
25
Willicombe M, Roufosse C, Brookes P, et al. Acute cellular rejection: impact of donor-specific antibodies and C4d. Transplantation 2014; 97(4): 433-439
(check this in PDF content)
26
Filippone EJ, Farber JL. The specificity of acute and chronic microvascular alterations in renal allografts. Clin Transplant 2013; 27(6): 790–798
(check this in PDF content)
27
Husain S, Sis B. Advances in the understanding of transplant glomerulopathy. Am J Kidney Dis 2013; 62(2): 352-363
(check this in PDF content)
28
Fotheringham J, Angel CA, McKane W. Transplant glomerulopathy: morphology, associations and mechanism. Nephron Clin Pract 2009; 113 (1): 1-7
(check this in PDF content)
29
Schinstock CA, Stegall M, Cosio F. New insights regarding chronic antibody-mediated rejection and its progression to transplant glomerulopathy. Curr Opin Nephrol Hypertens 2014; 23(6): 611-618 Авторы заявляют об отсутствии конфликта
(check this in PDF content)